Can a common diabetes drug work safely in kidney patients?
NCT ID NCT02895750
First seen Oct 31, 2025 · Last updated Jun 14, 2026 · Updated 36 times
Summary
This study tested the safety and effectiveness of a once-daily form of metformin (metformin XR) in 12 adults with type 2 diabetes and mild to moderate chronic kidney disease. Researchers measured blood sugar levels continuously and checked kidney and lactate levels over 12 weeks. The goal was to gather more data on how the drug works in people with kidney problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens Picardie
Amiens, 80054, France
Conditions
Explore the condition pages connected to this study.